A Toxicology for the 21st Century—Mapping the Road Ahead
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
The landmark publication by the National Research Council putting forward a vision of a toxicology for the 21st century in 2007 has created an atmosphere of departure in our field. The alliances formed, symposia and meetings held and the articles following are remarkable, indicating that this is an idea whose time has come. Most of the discussion centers on the technical opportunities to map pathways of toxicity and the financing of the program. Here, the other part of the work ahead shall be discussed, that is, the focus is on regulatory implementation once the technological challenges are managed, but we are well aware that the technical aspects of what the National Academy of Science report suggests still need to be addressed: A series of challenges are put forward which we will face in addition to finding a technical solution (and its funding) to set this vision into practice. This includes the standardization and quality assurance of novel methodologies, their formal validation, their integration into test strategies including threshold setting and finally a global acceptance and implementation. This will require intense conceptual steering to have all pieces of the puzzle come together.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Transforming Environmental Health Protection
Collins, F. S., Gray, G. M., & Bucher, J. R. (2008) · Science · doi:10.1126/science.1154619 · Cited by 630
Coecke, S., Balls, M., Bowe, G., Davis, J., Gstraunthaler, G., Hartung, T., Hay, R., Merten, O.-W., Price, A., Schechtman, L., et al. (2005) · Alternatives to Laboratory Animals · doi:10.1177/026119290503300313 · Cited by 371 · cited 1×
“Building on a workshop to identify the gaps for a GLP for in vitro approaches (Cooper-Hannan et al., 1999), and the parallel development of Good Cell Culture Practices (Coecke et al., 2005; Hartung et al., 2002), now some OECD guidance for in vitro toxicology is available (OECD, 2004).”
A Modular Approach to the ECVAM Principles on Test Validity
Hartung, T., Bremer, S., Casati, S., Coecke, S., Corvi, R., Fortaner, S., Gribaldo, L., Halder, M., Hoffmann, S., Roi, A. J., et al. (2004) · Alternatives to Laboratory Animals · doi:10.1177/026119290403200503 · Cited by 341 · cited 2×
“There are various challenges to the validation process as it is right now (Hartung et al., 2004), which we have discussed elsewhere (Ahr et al., 2008; Hartung, 2007a).”
Background
Cited by
Toxicology for the twenty-first century
Hartung, T. (2009) · Nature · doi:10.1038/460208a · Cited by 661
Self-citationToxicity testing in the 21st century: progress in the past decade and future perspectives
Krewski, D., Andersen, M. E., Tyshenko, M. G., Krishnan, K., Hartung, T., Boekelheide, K., Wambaugh, J. F., Jones, D., Whelan, M., Thomas, R., et al. (2020) · Archives of Toxicology · doi:10.1007/s00204-019-02613-4 · Cited by 383
Self-citationAre In Vitro Tests Suitable for Regulatory Use?
Hartung, T., & Daston, G. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp149 · Cited by 202
Human biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117
Alternative in vitro assays in nanomaterial toxicology
Hartung, T., & Sabbioni, E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.153 · Cited by 84
Bouhifd, M. (2015) · ALTEX · doi:10.14573/altex.1502091 · Cited by 69
The future of skin toxicology testing–three-dimensional bioprinting meets microfluidics
Ng, W. L., & Yeong, W. Y. (2019) · International Journal of Bioprinting · doi:10.18063/ijb.v5i2.1.237 · Cited by 48
“A paradigm shift in the testing models has occurred over the past few years; the implementation of non-animal testing strategy has spurred the development of numerous human-based three-dimensional (3D) in vitro testing models[4,5].”
Background
Metadata
- Authors
- Hartung, T.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-08
- Volume
- 109
- Issue
- 1
- Pages
- 18-23
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2155660185
- Cited by
- 104
- References
- 3
- FWCI
- 18.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.